| Summary of Activity Under Share-Based Compensation Plans | The following table summarizes the activity for stock appreciation rights, or SARs, under all share-based compensation plans for the nine months ended September 30, 2019:   
|   |   | Number of Awards |   |   | Weighted-Average Exercise Price Per Award |   |   | Weighted-Average Remaining Contractual Term |   | Aggregate Intrinsic Value(1) |   |  
|   |   | (in thousands) |   |   |   |   |   |   |   |   | (in millions) |   |  
| Outstanding as of December 31, 2018(2)(3) |   |   | 8,470 |   |   | $ | 26.82 |   |   | 6.1 years |   | $ | 272.1 |   |  
| Granted |   |   | — |   |   | $ | — |   |   |   |   |   |   |   |  
| Exercised(4) |   |   | (757 | ) |   | $ | 24.27 |   |   |   |   |   |   |   |  
| Forfeited(5) |   |   | (257 | ) |   | $ | 29.99 |   |   |   |   |   |   |   |  
| Outstanding as of September 30, 2019(2)(3) |   |   | 7,456 |   |   | $ | 26.97 |   |   | 5.3 years |   | $ | 82.8 |   |  
| Exercisable as of September 30, 2019(6) |   |   | 6,183 |   |   | $ | 26.63 |   |   | 4.9 years |   | $ | 71.1 |   |  
| Vested and expected to vest as of September 30, 2019 |   |   | 7,454 |   |   | $ | 26.97 |   |   | 5.3 years |   | $ | 82.8 |   |    
| (1) | The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards. |  
| (2) | Includes less than 0.1 million market condition SARs as of both September 30, 2019 and December 31, 2018. |  
| (3) | Includes 2.9 million and 3.1 million performance condition SARs as of September 30, 2019 and December 31, 2018, respectively, which represent the maximum amount that can vest. |  
| (4) | Includes less than 0.1 million performance condition SARs. |  
| (5) | Includes 0.2 million performance condition SARs. |  
| (6) | Includes less than 0.1 million market condition and 2.4 million performance condition SARs. |  The following table summarizes the activities for stock units under all share-based compensation plans for the nine months ended September 30, 2019:   
|   |   | Number of Shares |   |   | Weighted-Average Grant Date Fair Value Per Share |   |  
|   |   | (in thousands) |   |   |   |   |   |  
| Outstanding and nonvested as of December 31, 2018(1) |   |   | 1,611 |   |   | $ | 42.09 |   |  
| Granted(2) |   |   | 961 |   |   | $ | 55.48 |   |  
| Vested |   |   | (197 | ) |   | $ | 45.72 |   |  
| Forfeited(3) |   |   | (460 | ) |   | $ | 40.67 |   |  
| Outstanding and nonvested as of September 30, 2019(1) |   |   | 1,915 |   |   | $ | 48.78 |   |  
| Expected to vest as of September 30, 2019(4) |   |   | 1,636 |   |   | $ | 48.85 |   |    
| (1) | Includes 560,986 and 708,836 performance-based stock unit awards as of September 30, 2019 and December 31, 2018, respectively, which represents the maximum amount that can vest. |  
| (2) | Includes 209,182 performance-based stock unit awards, which represents the maximum amount that can vest. |  
| (3) | Includes 357,032 performance-based stock unit awards. |  
| (4) | Includes 312,757 performance-based stock unit awards. |  |